ARTICLE | Company News
Avid Therapeutics deal
July 11, 1994 7:00 AM UTC
Philadelphia-based Avid received an exclusive worldwide license to molecular targets involving the herpes family of viruses from ARCH Development Corp., the technology licensing affiliate of the Unive...